CONTRASTING CYTOKINE PROFILES IN THE SYNOVIUM OF DIFFERENT FORMS OF JUVENILE RHEUMATOID-ARTHRITIS AND JUVENILE SPONDYLOARTHROPATHY - PROMINENCE OF INTERLEUKIN-4 IN RESTRICTED DISEASE
Kj. Murray et al., CONTRASTING CYTOKINE PROFILES IN THE SYNOVIUM OF DIFFERENT FORMS OF JUVENILE RHEUMATOID-ARTHRITIS AND JUVENILE SPONDYLOARTHROPATHY - PROMINENCE OF INTERLEUKIN-4 IN RESTRICTED DISEASE, Journal of rheumatology, 25(7), 1998, pp. 1388-1398
Objective, To determine the pattern of expression of Type 1 and Type 2
cytokines in synovial tissues and fluids (SF) of patients with differ
ent forms of juvenile rheumatoid arthritis (JRA) and juvenile spondylo
arthropathy (JSpA), and to contrast these with findings in adult patie
nts with RE. Methods. Sixty-three SF mononuclear cell preparations and
synovial tissue samples from 50 patients with JRA or JSpA and 7 synov
ial tissues from patients with adult onset RA were analyzed by reverse
transcription polymerase chain reaction for the presence or absence o
f interleukin 2 (IL-2), tumor necrosis factor-beta (TNF-beta), interfe
ron-gamma (lFN-gamma), and IL-10 and IL-4 mRNA. Results, IL-4 mRNA was
identified significantly more often in the synovial compartrnent of p
atients with pauciarticular onset disease (JRA or JSpA) compared with
polyarticular onset JRA (58 vs 14%; p<0.01) or RA (29%). Similarly, IL
-4 mRNA was detected mon often in those with a persistently pauciartic
ular disease course compared to those with a polyarticular course (68
vs 30%; p<0.01). Furthermore, the combination of IL-4 and IL-10 mRNA w
as found more frequently in nonerosive compared with erosive disease (
38 vs 15%; p<0.05). IL-2 and TNF-D mRNA were found in all groups. IFN-
gamma mRNA was detected in 33% of those with systemic onset JRA compar
ed with 85% of other types of JRA (p<0.01). Conclusion. This study pro
vides further evidence of immunopathological differences between chron
ic forms of arthritis with childhood onset, and highlights similaritie
s with and differences from adult RA. Our findings suggest that IL-4,
possibly in combination with IL-10, has an antiinflammatory or disease
restricting role.